ID23385A - 4,5, diaril imidazol tersubstitutsi pada posisi 2 - Google Patents
4,5, diaril imidazol tersubstitutsi pada posisi 2Info
- Publication number
- ID23385A ID23385A IDW991681A ID991681A ID23385A ID 23385 A ID23385 A ID 23385A ID W991681 A IDW991681 A ID W991681A ID 991681 A ID991681 A ID 991681A ID 23385 A ID23385 A ID 23385A
- Authority
- ID
- Indonesia
- Prior art keywords
- diaril
- imidazol
- substituted
- substituted diaril
- imidazol substituted
- Prior art date
Links
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical group C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9713726.9A GB9713726D0 (en) | 1997-06-30 | 1997-06-30 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ID23385A true ID23385A (id) | 2000-04-20 |
Family
ID=10815101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW991681A ID23385A (id) | 1997-06-30 | 1998-06-26 | 4,5, diaril imidazol tersubstitutsi pada posisi 2 |
Country Status (28)
Country | Link |
---|---|
US (1) | US6300347B1 (de) |
EP (2) | EP0993456B1 (de) |
JP (1) | JP3704362B2 (de) |
KR (1) | KR20010013215A (de) |
CN (1) | CN1261885A (de) |
AR (1) | AR014886A1 (de) |
AT (1) | ATE275557T1 (de) |
AU (1) | AU744411B2 (de) |
BR (1) | BR9810955A (de) |
CA (1) | CA2291758A1 (de) |
CO (1) | CO4940462A1 (de) |
DE (1) | DE69826127T2 (de) |
ES (1) | ES2226164T3 (de) |
GB (1) | GB9713726D0 (de) |
HU (1) | HUP0003351A3 (de) |
ID (1) | ID23385A (de) |
IL (1) | IL133034A0 (de) |
NO (1) | NO996429D0 (de) |
NZ (1) | NZ501275A (de) |
PE (1) | PE99999A1 (de) |
PL (1) | PL337057A1 (de) |
PT (1) | PT993456E (de) |
RU (1) | RU2214408C2 (de) |
SK (1) | SK186599A3 (de) |
TR (1) | TR199903278T2 (de) |
TW (1) | TW429258B (de) |
WO (1) | WO1999001449A1 (de) |
ZA (1) | ZA985656B (de) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998007425A1 (en) | 1996-08-21 | 1998-02-26 | Smithkline Beecham Corporation | Imidazole compounds, compositions and use |
US7301021B2 (en) | 1997-07-02 | 2007-11-27 | Smithkline Beecham Corporation | Substituted imidazole compounds |
CA2346665A1 (en) | 1998-10-07 | 2000-04-13 | Smithkline Beecham Corporation | Novel treatment for stroke management |
EP1143957A3 (de) * | 1998-12-16 | 2002-02-27 | Warner-Lambert Company | Mek inhibitoren zur behandlung von arthritis |
US7101899B1 (en) * | 1999-04-23 | 2006-09-05 | Takeda Pharmaceutical Company Limited | 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
WO2000064872A1 (en) * | 1999-04-23 | 2000-11-02 | Vertex Pharmaceuticals Incorporated | INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) |
US6291457B1 (en) | 1999-07-01 | 2001-09-18 | Merck & Co., Inc. | Compounds having cytokine inhibitory activity |
US7122666B2 (en) | 1999-07-21 | 2006-10-17 | Sankyo Company, Limited | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses |
WO2001030778A1 (en) * | 1999-10-27 | 2001-05-03 | Novartis Ag | Thiazole and imidazo [4,5-b] pyridine compounds and their pharmaceutical use |
PL348924A1 (en) | 1999-11-10 | 2002-06-17 | Ortho Mcneil Pharm Inc | Substituted 2−aryl−3−(heteroaryl)−imidazo[1,2−a |
US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
DE60015594T2 (de) | 1999-11-22 | 2005-10-27 | Smithkline Beecham P.L.C., Brentford | Imidazolderivate und deren verwendung als raf kinase inhibitoren |
EP1235814B1 (de) | 1999-11-23 | 2004-11-03 | Smithkline Beecham Corporation | 3,4-DIHYDRO-(1H)CHINAZOLIN-2-ON-VERBINDUNGEN ALS CSBP/p38-KINASE-INHIBITOREN |
US7612065B2 (en) | 2000-04-21 | 2009-11-03 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-JUN N-terminal kinases (JNK) |
MXPA03008142A (es) | 2001-03-09 | 2003-12-12 | Pfizer Prod Inc | Nuevos compuestos antiinflamatorios de bencimidazol. |
MXPA03008144A (es) | 2001-03-09 | 2003-12-12 | Pfizer Prod Inc | Nuevos compuestos antiinflamatorios de triazolopiridinas. |
EP1247810B1 (de) | 2001-04-04 | 2005-09-07 | Pfizer Products Inc. | Neue Benzotriazole mit entzündungshemmender Wirkung |
EP2087908B1 (de) | 2001-06-26 | 2018-05-30 | Amgen Inc. | Antikörper gegen opgl |
CA2461100C (en) * | 2001-10-22 | 2009-12-01 | Tanabe Seiyaku Co., Ltd. | 4-imidazolin-2-one compounds |
AR039241A1 (es) | 2002-04-04 | 2005-02-16 | Biogen Inc | Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos |
DE10222103A1 (de) * | 2002-05-17 | 2003-11-27 | Merckle Gmbh Chem Pharm Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
ATE349210T1 (de) | 2002-07-09 | 2007-01-15 | Boehringer Ingelheim Pharma | Pharazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege |
US7037923B2 (en) | 2002-08-30 | 2006-05-02 | Pfizer, Inc. | Alkyl-[4-(trifluorophenyl)-oxazol-5-yl]-triazolo-pyridines |
US7005523B2 (en) | 2002-08-30 | 2006-02-28 | Pfizer Inc. | Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridines |
US6949652B2 (en) | 2002-08-30 | 2005-09-27 | Pfizer, Inc. | Crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5-yl]-[1,2,4]triazolo-[4,3-A]pyridine |
US7012143B2 (en) | 2002-08-30 | 2006-03-14 | Dombroski Mark A | Cycloalkyl-[4-(difluorophenyl)-oxazol-5-yl]-triazolo-pyridines |
PA8579601A1 (es) | 2002-08-30 | 2004-05-07 | Pfizer Prod Inc | Compuestos antiinflamatorios de di y trifloruro-triazolo-piridinas |
UA80295C2 (en) | 2002-09-06 | 2007-09-10 | Biogen Inc | Pyrazolopyridines and using the same |
EP1583535A4 (de) * | 2002-12-06 | 2008-03-19 | Scios Inc | Verfahren zur behandlung von diabetes |
EP1594459B1 (de) | 2002-12-30 | 2010-02-17 | Angiotech International Ag | Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung |
WO2004087653A2 (en) * | 2003-04-03 | 2004-10-14 | Merck & Co., Inc. | 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5 |
US20040229878A1 (en) * | 2003-05-13 | 2004-11-18 | Depuy Spine, Inc. | Transdiscal administration of specific inhibitors of P38 kinase |
US7344716B2 (en) * | 2003-05-13 | 2008-03-18 | Depuy Spine, Inc. | Transdiscal administration of specific inhibitors of pro-inflammatory cytokines |
US7553827B2 (en) * | 2003-08-13 | 2009-06-30 | Depuy Spine, Inc. | Transdiscal administration of cycline compounds |
US8273347B2 (en) * | 2003-05-13 | 2012-09-25 | Depuy Spine, Inc. | Autologous treatment of degenerated disc with cells |
US8361467B2 (en) | 2003-07-30 | 2013-01-29 | Depuy Spine, Inc. | Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints |
MXPA06001081A (es) * | 2003-07-31 | 2006-04-24 | Irm Llc | Compuestos biciclicos y composiciones como inhibidores de pdf. |
CA2540518A1 (en) * | 2003-10-02 | 2005-04-07 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
US8895540B2 (en) | 2003-11-26 | 2014-11-25 | DePuy Synthes Products, LLC | Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor |
WO2005063716A1 (en) | 2003-12-22 | 2005-07-14 | Janssen Pharmaceutica, N.V. | Imidazoles and their use cck-1 receptor modulators |
US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
EP1810972B1 (de) * | 2004-11-10 | 2012-01-25 | Ono Pharmaceutical Co., Ltd. | Stickstoffhaltige heterocyclische verbindung und deren pharmazeutische verwendung |
PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
NZ560264A (en) * | 2005-02-28 | 2009-11-27 | Merckle Gmbh | 2-sulfinyl-and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors |
US7968572B2 (en) | 2005-10-03 | 2011-06-28 | Ono Pharmaceuticals Co., Ltd. | Nitrogen-containing heterocyclic compound and pharmaceutical application thereof |
EP1953148B1 (de) | 2005-10-28 | 2012-02-29 | Takeda Pharmaceutical Company Limited | Heterocyclische amidverbindung und anwendung davon |
ES2301380B1 (es) | 2006-08-09 | 2009-06-08 | Laboratorios Almirall S.A. | Nuevos derivados de 1,7-naftiridina. |
ES2320955B1 (es) | 2007-03-02 | 2010-03-16 | Laboratorios Almirall S.A. | Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida. |
ES2329639B1 (es) | 2007-04-26 | 2010-09-23 | Laboratorios Almirall S.A. | Nuevos derivados de 4,8-difenilpoliazanaftaleno. |
EP1992344A1 (de) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 Alpha als therapeutisches Target für Erkrankungen, die mit einer FGFR3- Mutation assoziiert sind |
JP2010528662A (ja) * | 2007-06-05 | 2010-08-26 | ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド,ア ボディー コーポレイト | T細胞サイトカイン誘導表面分子およびその使用 |
US20090162351A1 (en) * | 2007-12-21 | 2009-06-25 | Depuy Spine, Inc. | Transdiscal administration of inhibitors of p38 MAP kinase |
US8986696B2 (en) * | 2007-12-21 | 2015-03-24 | Depuy Mitek, Inc. | Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints |
EP2108641A1 (de) | 2008-04-11 | 2009-10-14 | Laboratorios Almirall, S.A. | Neue substituierte Spiro[Cycloalkyl-1,3'-indo]-2'(1'H)-on-Derivate und ihre Verwendung als p38 mitogen-activated Kinase Inhibitoren |
EP2113503A1 (de) | 2008-04-28 | 2009-11-04 | Laboratorios Almirall, S.A. | Neue substituierte Indolin-2-on- Derivate und ihre Verwendung als p39 mitogen-activated Kinase Inhibitoren |
TWI435874B (zh) * | 2008-10-31 | 2014-05-01 | Toray Industries | 環己烷衍生物及其醫藥用途 |
EP2322176A1 (de) | 2009-11-11 | 2011-05-18 | Almirall, S.A. | Neue 7-Phenyl-[1,2,4]triazol[4,3-a]pyridin-3(2H)on-Derivate |
US20120270251A1 (en) * | 2009-12-22 | 2012-10-25 | Csir | Inhibition of the activity of kinase and synthetase enzymes |
JP2013523766A (ja) * | 2010-03-31 | 2013-06-17 | グラクソ グループ リミテッド | キナーゼ阻害剤としてのイミダゾリル‐イミダゾール |
WO2017151409A1 (en) | 2016-02-29 | 2017-09-08 | University Of Florida Research Foundation, Incorporated | Chemotherapeutic methods |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL104369A0 (en) * | 1992-01-13 | 1993-05-13 | Smithkline Beecham Corp | Novel compounds and compositions |
US5916891A (en) | 1992-01-13 | 1999-06-29 | Smithkline Beecham Corporation | Pyrimidinyl imidazoles |
AU3592493A (en) * | 1992-01-13 | 1993-08-03 | Smithkline Beecham Corporation | Pyridyl substituted imidazoles |
ZA945363B (en) | 1993-07-21 | 1995-03-14 | Smithkline Beecham Corp | Novel compounds |
US5620999A (en) | 1994-07-28 | 1997-04-15 | Weier; Richard M. | Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation |
EP0854870B1 (de) | 1995-10-06 | 2009-06-10 | Merck & Co., Inc. | Substituierte imidazole mit krebsremmender und cytokininhibierender wirkung |
US5717100A (en) * | 1995-10-06 | 1998-02-10 | Merck & Co., Inc. | Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
KR100568438B1 (ko) | 1997-04-24 | 2006-04-07 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 염증성 질환의 치료에 유용한 치환된 이미다졸, 이의 제조방법 및 이를 포함하는 약제학적 조성물 |
JP4380803B2 (ja) | 1997-06-12 | 2009-12-09 | アベンテイス・フアルマ・リミテツド | イミダゾリル−環式アセタール |
EP0994870A4 (de) | 1997-06-19 | 2002-10-23 | Smithkline Beecham | Neue,durch einen aryloxyrest substituierte imidazolverbindungen |
US6040320A (en) | 1997-06-30 | 2000-03-21 | Ortho-Mcneil Pharmaceutical, Inc. | 2-substituted imidazoles useful in the treatment of inflammatory diseases |
TW517055B (en) | 1997-07-02 | 2003-01-11 | Smithkline Beecham Corp | Novel substituted imidazole compounds |
CA2295762A1 (en) | 1997-07-02 | 1999-01-14 | Ravi Shanker Garigipati | Novel cycloalkyl substituted imidazoles |
AR016294A1 (es) | 1997-07-02 | 2001-07-04 | Smithkline Beecham Corp | Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion |
FR2772377B1 (fr) | 1997-12-12 | 2000-01-07 | Synthelabo | Derives de 1-(1-h-imidazol-2-yl)pyrrolidines et 1-(1-h-imidazol-2-ylpiperidines), leur preparation et leur application en therapeutique |
-
1997
- 1997-06-30 GB GBGB9713726.9A patent/GB9713726D0/en active Pending
-
1998
- 1998-06-11 TW TW087109301A patent/TW429258B/zh active
- 1998-06-25 CO CO98036362A patent/CO4940462A1/es unknown
- 1998-06-26 BR BR9810955-3A patent/BR9810955A/pt not_active IP Right Cessation
- 1998-06-26 NZ NZ501275A patent/NZ501275A/en unknown
- 1998-06-26 HU HU0003351A patent/HUP0003351A3/hu unknown
- 1998-06-26 AR ARP980103093A patent/AR014886A1/es unknown
- 1998-06-26 KR KR19997011203A patent/KR20010013215A/ko not_active Application Discontinuation
- 1998-06-26 TR TR1999/03278T patent/TR199903278T2/xx unknown
- 1998-06-26 AU AU88015/98A patent/AU744411B2/en not_active Ceased
- 1998-06-26 DE DE69826127T patent/DE69826127T2/de not_active Expired - Fee Related
- 1998-06-26 RU RU2000101820/04A patent/RU2214408C2/ru not_active IP Right Cessation
- 1998-06-26 WO PCT/EP1998/003930 patent/WO1999001449A1/en not_active Application Discontinuation
- 1998-06-26 PE PE1998000569A patent/PE99999A1/es not_active Application Discontinuation
- 1998-06-26 CN CN98806673A patent/CN1261885A/zh active Pending
- 1998-06-26 AT AT98939541T patent/ATE275557T1/de not_active IP Right Cessation
- 1998-06-26 ID IDW991681A patent/ID23385A/id unknown
- 1998-06-26 PT PT98939541T patent/PT993456E/pt unknown
- 1998-06-26 CA CA002291758A patent/CA2291758A1/en not_active Abandoned
- 1998-06-26 SK SK1865-99A patent/SK186599A3/sk unknown
- 1998-06-26 IL IL13303498A patent/IL133034A0/xx unknown
- 1998-06-26 JP JP50628899A patent/JP3704362B2/ja not_active Expired - Fee Related
- 1998-06-26 US US09/446,885 patent/US6300347B1/en not_active Expired - Fee Related
- 1998-06-26 EP EP98939541A patent/EP0993456B1/de not_active Expired - Lifetime
- 1998-06-26 EP EP03026996A patent/EP1396491A3/de not_active Withdrawn
- 1998-06-26 ES ES98939541T patent/ES2226164T3/es not_active Expired - Lifetime
- 1998-06-26 PL PL98337057A patent/PL337057A1/xx unknown
- 1998-06-29 ZA ZA985656A patent/ZA985656B/xx unknown
-
1999
- 1999-12-23 NO NO996429A patent/NO996429D0/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID23385A (id) | 4,5, diaril imidazol tersubstitutsi pada posisi 2 | |
NO2006016I1 (no) | 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat | |
DE69933287D1 (de) | 12,13-modifizierte epothilon-derivate | |
DK1000048T3 (da) | Substituerede 1,2,3,4-tetrahydronapthalenderivater | |
DK1005446T3 (da) | N-aroylphenylalaninderivater | |
ATE235220T1 (de) | Resorcinderivate | |
ID22781A (id) | Turunan-turunan nikotinamida | |
DE69831181D1 (de) | Positionsbestimmung | |
DE69817186D1 (de) | Diaminorhodamin-derivate | |
ATE255098T1 (de) | Substituierte chromanderivate | |
DK1003719T3 (da) | Mikrobicide N-sulfonylglycin-alkynyloxyphenethylamidderivater | |
ID21413A (id) | Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on | |
TR199800988A3 (tr) | 5' Deoksi-Sitidin türevleri. | |
ATE255099T1 (de) | Substituierte chromanderivate | |
DE59808442D1 (de) | Stirnplanfräsmaschine | |
ATE227282T1 (de) | 2,4-diaminopyrimidin-derivate | |
EE04089B1 (et) | 1,3,4-oksadiasolooni derivaadid | |
ATE292632T1 (de) | Cis-disubstituierte aminocycloalkyl-pyrrolidin- derivate | |
DE69828780D1 (de) | Amidinocamptpthecin-derivate | |
NO981495D0 (no) | Phenoxymetylpiperidin-derivater | |
DK0967869T3 (da) | Fungicidblandinger | |
DK0966437T3 (da) | 5-Aroylnaphthalenderivater | |
DK1001978T3 (da) | Angiotensinderivater | |
DK1068200T3 (da) | 2,4,4-trisubstituerede-1,3-dioxolanfungicider | |
ID24047A (id) | Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on |